A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

COVID-19 and influenza vaccine-hesitancy subgroups




TekijätMäki, Karl O.; Karlsson, Linda C.; Kaakinen, Johanna K.; Schmid, Philipp; Lewandowsky, Stephan; Antfolk, Jan; Soveri, Anna

KustantajaPublic Library of Science

Julkaisuvuosi2024

JournalPLoS ONE

Tietokannassa oleva lehden nimiPloS one

Lehden akronyymiPLoS One

Artikkelin numeroe0308159

Vuosikerta19

Numero7

ISSN1932-6203

eISSN1932-6203

DOIhttps://doi.org/10.1371/journal.pone.0308159

Verkko-osoitehttps://doi.org/10.1371/journal.pone.0308159

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/457551063


Tiivistelmä
Health communicators are faced with the challenge that people can hesitate vaccines for different reasons. Our aim was to identify and describe the qualities of distinct COVID-19 and influenza vaccine-hesitancy subgroups to facilitate the development of tailored vaccine-hesitancy communication. In two studies, we used agglomerative hierarchical cluster analysis to identify COVID-19 (N = 554) and influenza (N = 539) vaccine-hesitancy subgroups in the general population based on nine vaccine hesitancy-related variables (intent to get vaccinated, perceived vaccine safety, perceived vaccine efficacy, perceived disease threat, perceived vaccination responsibility, perceived vaccination convenience, distrust in authorities, conspiracy mentality, and reliance on anecdotal testimonies). We identified and described six distinct COVID-19 vaccine-hesitancy subgroups (the Vaccination Positive, the Ambivalent, the Fearing Skeptic, the Unconvinced, the Constrained Skeptic, and the Vaccination Opponent), and three influenza vaccine-hesitancy subgroups (the Vaccination Positive, the Complacent, and the Vaccination Opponent), with different levels of hesitancy. We discuss the implications of the results for health communicators. Our results shed light on the (dis)similarities between people who hesitate COVID-19 and influenza vaccines and suggest that there is greater variety in hesitancy concerning COVID-19 vaccinations than influenza vaccinations. These findings can be used to design and test tailored vaccination messages.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
Funding: This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 964728 (JITSUVAX). KOM was funded by the Faculty of Social Sciences at the University of Turku (www.utu.fi/en/university/faculty-of-socialsciences). JKK and KOM received funding from the Strategic Research Council’s LITERACY program


Last updated on 2025-27-01 at 20:02